Literature DB >> 12195390

Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand.

Jun Ohashi1, Izumi Naka, Jintana Patarapotikul, Hathairad Hananantachai, Sornchai Looareesuwan, Katsushi Tokunaga.   

Abstract

A CCTTT microsatellite repeat in the inducible nitric oxide synthase (iNOS) promoter was analyzed among 256 adult patients with severe Plasmodium falciparum malaria and 179 adult patients with mild malaria living in northwestern Thailand. Genotypes with longer forms of the CCTTT repeat (alleles of > or =15 repeats) were significantly associated with severe malaria (odds ratio [OR], 2.14; P=.0029, chi(2) test). More interestingly, the summed repeat number of both microsatellite alleles in an individual was found to be a significant risk factor for severe malaria (OR, 1.11; logistic regression analysis, P=.0041). The single nucleotide substitution, -954G-->C, in the iNOS promoter was rare in Thai patients with malaria. No variations were detected in the iNOS promoter region containing functional NF-kappaB elements at -5.2, -5.5, -5.8, and -6.1 kb upstream of the iNOS transcriptional start site. Thus, a CCTTT repeat in the iNOS promoter may play a key role in the pathogenesis of severe malaria.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12195390     DOI: 10.1086/341779

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

1.  Extended linkage disequilibrium surrounding the hemoglobin E variant due to malarial selection.

Authors:  Jun Ohashi; Izumi Naka; Jintana Patarapotikul; Hathairad Hananantachai; Gary Brittenham; Sornchai Looareesuwan; Andrew G Clark; Katsushi Tokunaga
Journal:  Am J Hum Genet       Date:  2004-04-27       Impact factor: 11.025

2.  The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers.

Authors:  Charlotta Ryk; Sai-Mei Hou; Göran Pershagen; N Peter Wiklund; Fredrik Nyberg; Petra J de Verdier
Journal:  Tumour Biol       Date:  2014-01-10

3.  Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale.

Authors:  Michael Hawkes; Robert Opika Opoka; Sophie Namasopo; Christopher Miller; Andrea L Conroy; Lena Serghides; Hani Kim; Nisha Thampi; W Conrad Liles; Chandy C John; Kevin C Kain
Journal:  Med Hypotheses       Date:  2011-07-13       Impact factor: 1.538

4.  Polymorphisms in host genes encoding NOSII, C-reactive protein, and adhesion molecules thrombospondin and E-selectin are risk factors for Plasmodium falciparum malaria in India.

Authors:  K Kanchan; S S Pati; S Mohanty; S K Mishra; S K Sharma; S Awasthi; V Venkatesh; S Habib
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-21       Impact factor: 3.267

5.  The CCTTT pentanucleotide microsatellite in iNOS promoter influences the clinical outcome in P. falciparum infection.

Authors:  G Dhangadamajhi; B N Mohapatra; S K Kar; M R Ranjit
Journal:  Parasitol Res       Date:  2009-01-20       Impact factor: 2.289

6.  NOS2 variants reveal a dual genetic control of nitric oxide levels, susceptibility to Plasmodium infection, and cerebral malaria.

Authors:  Maria de Jesus Trovoada; Madalena Martins; Riadh Ben Mansour; Maria do Rosário Sambo; Ana B Fernandes; Lígia Antunes Gonçalves; Artur Borja; Roni Moya; Paulo Almeida; João Costa; Isabel Marques; M Paula Macedo; António Coutinho; David L Narum; Carlos Penha-Gonçalves
Journal:  Infect Immun       Date:  2013-12-30       Impact factor: 3.441

7.  A non-synonymous SNP in the NOS2 associated with septic shock in patients with sepsis in Chinese populations.

Authors:  Zhifu Wang; Kai Feng; Maoxing Yue; Xiaoguang Lu; Qihan Zheng; Hongxing Zhang; Yun Zhai; Peiyao Li; Lixia Yu; Mi Cai; Xiumei Zhang; Xin Kang; Weihai Shi; Xia Xia; Xi Chen; Pengbo Cao; Yuanfeng Li; Huipeng Chen; Yan Ling; Yuxia Li; Fuchu He; Gangqiao Zhou
Journal:  Hum Genet       Date:  2012-11-30       Impact factor: 4.132

8.  Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial.

Authors:  Michael Hawkes; Robert O Opoka; Sophie Namasopo; Christopher Miller; Kevin E Thorpe; James V Lavery; Andrea L Conroy; W Conrad Liles; Chandy C John; Kevin C Kain
Journal:  Trials       Date:  2011-07-13       Impact factor: 2.279

9.  Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA.

Authors:  Kouyuki Hirayasu; Jun Ohashi; Koichi Kashiwase; Hathairad Hananantachai; Izumi Naka; Atsuko Ogawa; Minoko Takanashi; Masahiro Satake; Kazunori Nakajima; Peter Parham; Hisashi Arase; Katsushi Tokunaga; Jintana Patarapotikul; Toshio Yabe
Journal:  PLoS Pathog       Date:  2012-03-08       Impact factor: 6.823

10.  A functional polymorphism in the IL1B gene promoter, IL1B -31C>T, is not associated with cerebral malaria in Thailand.

Authors:  Jun Ohashi; Izumi Naka; Akihiro Doi; Jintana Patarapotikul; Hathairad Hananantachai; Noppadon Tangpukdee; Sornchai Looareesuwan; Katsushi Tokunaga
Journal:  Malar J       Date:  2005-08-14       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.